Global leaders unite in support of immunization, health security and prosperity

The impact of immunization goes beyond health – it is about prosperity, security, and economic development. Ensuring equitable access to vaccines is a global priority, and the European Union (EU) plays a leading role in this effort.

In 2003, the EU first partnered up with Gavi, the Vaccine Alliance, to strengthen global health systems and has continued its successful collaboration ever since

• The Gavi 6.0 Pledging Summit
• Gavi 6.0 goals (2026-2030)
• The EU and Gavi

The Gavi 6.0 Pledging Summit

On 25 June 2025 in Brussels, the EU co-hosted - with the Gates Foundation -  the Gavi 6.0 High-Level Pledging Summit, with the close support of other Gavi donors and implementing countries. The summit brought together a record number of global leaders from government, partner organisations, vaccine manufacturers, civil society, and the private sector, to secure crucial investments in vaccination programmes.

Donors pledged more than €7.7 billion towards a target budget of €10.2bn for the 2026-2030 period. This included a total pledge of more than €2bn from Team Europe –  the EU and its member states – collectively the largest donor to Gavi. Of this amount, the European Commission pledged €360 million.

Additional commitments were made, including:

• €3.8 billion in complementary financing from development finance institutions
• up to €170.6 million in cost savings for Gavi-supported programmes announced by vaccine manufacturers
• more than €127 million in private sector partnerships focused on immunisation delivery

Gavi 6.0 goals (2026-2030)

Gavi's 2026–2030 strategy (Gavi 6.0) is the final push to achieve global immunisation and health security targets ahead of the 2030 Sustainable Development Goals (SDG) deadline. 

https://ec.europa.eu/assets/comm/Infogram/GAVI/en/index_en.htmlText version

During the 2026-2030 period, Gavi aims to

• expand vaccine programmes and invest in emergency stockpiles to prevent outbreak-prone diseases at source
• ensure vaccine access for the world’s poorest countries in a possible future health crisis
• support local vaccine production through regional partnerships

The EU and Gavi

The EU has a long-standing partnership with Gavi, contributing over €3.2bn since 2003 to advance global immunization. This includes significant support through the COVAX Advance Market Commitment and the European Investment Bank financial instruments, part of the EU’s Global Coronavirus Response.

Together, the EU and its member states – in a Team Europe approach – remain Gavi's largest contributors, providing over €6.5 billion during the Gavi 5.0 strategic period (2021–2025). In September 2024, the Commission announced a new funding pledge of €260m, for the years 2026–2027. The funds will contribute to Gavi's 2030 goal to help protect 500 million children around the world, strengthen immunization systems, and boost global health security by increasing readiness to respond to disease outbreaks.

The 2025 pledging Summit builds on the successful launch of Gavi's 6.0 Investment Opportunity in June 2024 in Paris, co-hosted by France and the African Union, which raised $2.4 billion towards the $9bn funding target of Gavi. 

Related links

Gavi, the Vaccine Alliance

Joint press release by the European Commission and the European Council on the European Union and the Bill & Melinda Gates Foundation co-hosting Gavi High Level Pledging Summit

Share this article: